Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus

Objective: To estimate the common effect size of HLA-DRB1 and -DQB1 alleles on systemic lupus erythematosus (SLE) susceptibility across Latin America populations through a meta-analysis. Methods: Case-control studies on HLA class II association with SLE in Latin America were searched up to August 20...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2008
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23345
Acceso en línea:
https://doi.org/10.1016/j.autrev.2007.12.002
https://repository.urosario.edu.co/handle/10336/23345
Palabra clave:
Amino acid
Hla dqb1 antigen
Hla dr antigen
Peptide
Allele
Case control study
Confidence interval
Controlled study
Data extraction
Female
Genetic polymorphism
Genotype
Haplotype
Human
Major clinical study
Physical chemistry
Review
South and central america
Statistical analysis
Systemic lupus erythematosus
Adult
Alleles
Case-control studies
Female
Gene frequency
Genetic predisposition to disease
Genotype
Haplotypes
Hla-dq antigens
Hla-dr antigens
Humans
Latin america
Middle aged
Hla antigens/alleles
Hla haplotypes
Latin america
Meta-analysis
Systemic lupus erythematosus
genetic
systemic
Lupus erythematosus
Polymorphism
Rights
License
Abierto (Texto Completo)
Description
Summary:Objective: To estimate the common effect size of HLA-DRB1 and -DQB1 alleles on systemic lupus erythematosus (SLE) susceptibility across Latin America populations through a meta-analysis. Methods: Case-control studies on HLA class II association with SLE in Latin America were searched up to August 2007. The effect summary odds ratios (ORs) and 95% confidence intervals (CIs) were obtained by means of the random effect model. Results: Eleven studies were selected, which included 747 cases and 1180 controls. Associations with SLE susceptibility were found for HLA-DR2 (OR: 1.75; 95% CI: 1.40-2.19) and -DR3 (OR: 2.02; 95% CI: 1.44-2.83) groups. HLA-DRB1*0301 allele disclosed the strongest association (OR: 2.14; 95% CI: 1.28-3.56). HLA-DR3-DQ2 haplotype was a risk factor (OR: 2.92; 95% CI: 1.66-5.14). A protective effect was found for the HLA-DR5 group (OR: 0.43; 95% CI: 0.27-0.67), mainly due to a negative association between HLA-DRB1*1101 allele and disease (OR: 0.21; 95% CI: 0.06-0.72). Functional analysis of susceptibility and protective alleles revealed physicochemical differences of critical amino acids shaping the peptide-binding groove at DR? chain allowing us to infer an approach to understand the role of HLA in SLE. No significant association was established for HLA-DQB1 alleles. Conclusions: HLA-DRB1 gene is a mayor factor for development of SLE in Latin Americans. © 2007 Elsevier B.V. All rights reserved.